Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study

Saved in:
Bibliographic Details
Published inBritish journal of cancer Vol. 128; no. 5; pp. 707 - 710
Main Authors van der Kooij, Monique K., Joosse, Arjen, Suijkerbuijk, Karijn P. M., Aarts, Maureen J. B., van den Berkmortel, Franchette W. P. J., Blank, Christian U., Boers-Sonderen, Marye J., van den Eertwegh, Alfonsus J. M., de Groot, Jan Willem B., Haanen, John B. A. G., Hospers, Geke A. P., Piersma, Djura, van Rijn, Rozemarijn S., van der Veldt, Astrid A. M., Vreugdenhil, Gerard, Westgeest, Hans M., Wouters, Michel W. J. M., Dekkers, Olaf M., Kapiteijn, Ellen
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 23.03.2023
Nature Publishing Group
Subjects
692/4028/67/1059/2325
692/4028/67/1813/1634
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cohort Studies
Correspondence
Drug Resistance
Epidemiology
Humans
Melanoma
Melanoma - drug therapy
Molecular Medicine
Nivolumab - therapeutic use
Oncology
PD-1 protein
Programmed Cell Death 1 Receptor - therapeutic use
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0007-0920
1532-1827
DOI:10.1038/s41416-022-02088-8